AstraZeneca PLC: company profile and market research reports
AstraZeneca PLC is profiled in 48 Custom Market Insights market research reports, spanning healthcare. Our analysts cover the company in the Bile Acid Sequestrants, Ozempic, Perioral Dermatitis Treatment, Oophoritis Treatment and New Oral Anticoagulants markets, among others, where it is tracked as one of the companies shaping competition. In each study, the AstraZeneca PLC profile looks at its business overview, product and service portfolio, financial performance where it is disclosed, and strategic moves such as expansions, acquisitions, partnerships and new product launches. A dedicated AstraZeneca PLC company profile brings this together in one document: a global and market level overview, core segments, financials as available, market rank and share, products and services, and recent developments.
Global level overview
- Headquarters
- Cambridge, United Kingdom
- Founded
- 1913
- Employees
- 70,600 (2019)
- Ownership
- Public (listed on New York Stock Exchange)
- Revenue
- USD 24.4 Bn (2019)
- Website
- astrazeneca.com
What the AstraZeneca PLC profile covers
- Company overviewbusiness model, history and geographic footprint
- Key executivesleadership team and decision makers
- Product portfolioproducts and services relevant to each market
- Financial overviewrevenue, segment results and recent performance
- Operating business segmentshow the business is organised and where it earns
- Business performancemarket position, share and growth in the studied markets
- Recent developmentslaunches, partnerships, acquisitions and expansions
Top management of AstraZeneca PLC
- Pascal SoriotChief Executive Officer, Board memberSince October 2012
- Leif JohanssonChairperson, Board memberSince April 2012
- Marc DunoyerChief Financial OfficerSince November 2013
- Geneviève BergerBoard of directors memberSince April 2012
- Dougan McKellarDirector
- Graham ChipchaseBoard member
Recent news about AstraZeneca PLC
- AstraZeneca Moves Operations to SAP Cloud to Speed Up AITechnology Magazine · 12 November 2026
SAP Chief Customer Officer Thomas Saueressig explains how migrating legacy servers unlocks AI and streamlines global workflows ...
- Compugen Ltd (CGEN) Q3 2026 Earnings Call Highlights: Revenue Doubles as Gilead and AstraZeneca ...Yahoo Finance · 12 November 2026
Compugen Ltd (CGEN) posted $3.8 million in Q3 2026 revenue, completed MAIA-ovarian enrollment with data due by Q1 2027, and holds $117.5 million in cash to fund operations into 2029.
Headlines and excerpts from the publishers. Links open their websites.
Reports that profile AstraZeneca PLC
- Global Bile Acid Sequestrants Market 2026 – 2035Healthcare · May 2026
- Global Ozempic Market 2025 – 2034Healthcare · December 2025
- Global Perioral Dermatitis Treatment Market 2025 – 2034Healthcare · October 2025
- Global Oophoritis Treatment Market 2025 – 2034Healthcare · October 2025
- Global New Oral Anticoagulants Market 2025 – 2034Healthcare · August 2025
- Global Targeted Drug Delivery Market 2025 – 2034Healthcare · August 2025
- Global Ultomiris Drug Market 2025 – 2034Healthcare · July 2025
- Global Alzheimer’s Drug Market 2025 – 2034Healthcare · June 2025
- Global mRNA Cancer Vaccine Market 2025 – 2034Healthcare · June 2025
- Global Ascites Market 2024–2033Healthcare · October 2024
- Global Acute Respiratory Infection Market 2024–2033Healthcare · July 2024
- Europe Biotechnology Market 2024–2033Healthcare · July 2024
- US Biotechnology Market 2024–2033Healthcare · June 2024
- Global Non-Small-Cell Lung Cancer Drug Market 2024–2033Healthcare · April 2024
- Global Prostate Cancer Market 2024–2033Healthcare · April 2024
- Global mTOR Inhibitors Market 2024–2033Healthcare · April 2024
- Global Oral Cancer Treatment Market 2024–2033Healthcare · April 2024
- Global CD Antigen Cancer Therapy Market 2024–2033Healthcare · April 2024
- Global Colorectal Cancer Market 2024–2033Healthcare · April 2024
- Global Cancer Supportive Care Drugs Market 2024–2033Healthcare · April 2024
- Global Cancer Pain Market 2024–2033Healthcare · April 2024
- Global Breast Cancer Therapeutics Market 2024–2033Healthcare · April 2024
- Global Cancer Biologics Market 2024–2033Healthcare · April 2024
- Global Bladder Cancer Market 2024–2033Healthcare · April 2024
- Global Cancer Cachexia Market 2024–2033Healthcare · April 2024
- Global Lipid Nanoparticles Market 2024–2033Healthcare · March 2024
- Global Cancer Monoclonal Antibodies Market 2024–2033Healthcare · March 2024
- Global Anal Cancer Market 2024–2033Healthcare · March 2024
- Global Lung Tumor Market 2024–2033Healthcare · March 2024
- Global Gene Silencing Market 2024–2033Healthcare · March 2024
- Global Endometrial Cancer Market 2024–2033Healthcare · March 2024
- Global Bispecific Antibodies Market 2024–2033Healthcare · March 2024
- Global Cancer Monoclonal Antibody Testing Market 2024–2033Healthcare · March 2024
- Global Cancer Monoclonal Antibodies Market 2024–2033Healthcare · March 2024
- Global Cancer Immunotherapy Market 2024–2033Healthcare · March 2024
- Global PARP Inhibitors Market 2024–2033Healthcare · March 2024
- Global Personalized Cancer Medicine Market 2024–2033Healthcare · March 2024
- Global Penile Cancer Treatment Market 2024–2033Healthcare · March 2024
- Global Pitavastatin Market 2024–2033Healthcare · December 2023
- Global Nifedipine Market 2024–2033Healthcare · December 2023
- Global Antimicrobial Peptides Market 2024–2033Healthcare · December 2023
- Global Preventive Vaccine Market 2024–2033Healthcare · December 2023
- Global Respiratory Syncytial Virus Vaccine Market 2024–2033Healthcare · October 2023
- Global Keytruda Market 2024–2033Healthcare · September 2023
- Global Gardasil Market 2024–2033Healthcare · September 2023
- Europe Regenerative Medicine Market 2024–2033Healthcare · September 2023
- Global Chlorpheniramine Maleate Market 2024–2033Healthcare · July 2023
- Global Pharmaceutical Elixir Market 2024–2033Healthcare · June 2023
What our reports say about AstraZeneca PLC
Each report above includes a profile of AstraZeneca PLC: business overview, products and services, financials where disclosed and recent developments. Request a free sample to see the profile.
Frequently asked questions
How many Custom Market Insights reports profile AstraZeneca PLC?
AstraZeneca PLC is profiled in 48 of our market research reports, including the Global Bile Acid Sequestrants Market 2026 – 2035, Global Ozempic Market 2025 – 2034, Global Perioral Dermatitis Treatment Market 2025 – 2034.
Which industries do these reports cover?
Healthcare.
What does the AstraZeneca PLC company profile include?
Global level overview, Market level overview, Core segments, Financials, as available, Strategic information, Market rank and share, Products and services, Recent developments.
How much does the AstraZeneca PLC company profile cost?
$140 for the PDF, delivered by email. More companies can be added at checkout: 2nd to 5th profile $90 each, 6th onward $70 each.
Can I see a sample first?
Yes. Request a free sample and an analyst will send it by email, usually within one business day.
